| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Iterum Therapeutics Plc (ITRM) has 2 insiders with recent SEC Form 4 filings, including 3 buys and 9 sells. ITRM is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 241.0K | $7.2K | - | |
| Other | 200.0K | $6.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 7, 2022 | Dunne Michael W. | Director | Buy | 10,000 | $2.22 | $22,200.00 | +39.1% | -42.0% | -63.6% | |
| Mar 14, 2022 | Matthews Judith M. | Chief Financial Officer | Sale+OE | 47,132 | $0.38 | $17,910.16 | -36.6% | -42.7% | -82.5% | |
| Feb 12, 2021 | Denner Alexander J66 | 10% Owner | Sell | 20,619,949 | $2.43 | $50,007,284.23 | -66.0% | - | - | |
| Jan 26, 2021 | Fishman Corey N. | President &CEO | Sell | 85,445 | $1.73 | $147,819.85 | -21.0% | - | - | |
| Jan 26, 2021 | Matthews Judith M. | Chief Financial Officer | Sell | 33,868 | $1.73 | $58,591.64 | -54.2% | - | - | |
| Jan 26, 2021 | Dunne Michael W. | Director | Sell | 33,143 | $1.73 | $57,337.39 | -11.4% | - | - | |
| Oct 27, 2020 | Dunne Michael W. | Chief Scientific Officer | Buy | 61,540 | $0.00 | - | +41.6% | - | - | |
| Sep 30, 2020 | Matthews Judith M. | Chief Financial Officer | Sell | 56,130 | $1.64 | $92,053.20 | -100% | - | - | |
| Jun 2, 2020 | Sofinnova Venture Partners Ix, L.P. | 10% Owner | Sell | 500,000 | $1.62 | $812,080.00 | -14.9% | - | - | |
| Nov 30, 2018 | Kelly David George | Director | Buy | 10,000 | $6.29 | $62,887.00 | +104.7% | - | - |